1419 — Human Health Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$379.55m
- HK$55.37m
- HK$1.00bn
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 34.7 | -39 | 169 | 445 | 239 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.32 | 24.5 | 7.21 | -13.2 | 71.1 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.47 | -23.3 | -158 | -199 | 280 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 50.7 | 37.5 | 85.5 | 296 | 664 |
Capital Expenditures | -8.61 | -11.5 | -14.1 | -76.5 | -84 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -60.4 | -7.52 | 9.28 | -127 | -251 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -69 | -19 | -4.77 | -203 | -335 |
Financing Cash Flow Items | -0.146 | -4.66 | -2.87 | -2.83 | -7.93 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.5 | -64.7 | -59.3 | -67.4 | -178 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -20.3 | -46.4 | 22 | 25 | 149 |